Key result
Targeted next-generation sequencing enriched the genomic region of interest by a mean factor of 2169 compared with whole genome coverage, detecting disease-causing mutations in 6 patients.
Why the study?
Does targeted next-generation sequencing allow for fast and comprehensive genetic characterization of patients with inherited cardiomyopathies?
Population
Patients with hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM)
Design
Other
Authors
Loading...
May offer cost-efficient genetic screening in hereditary cardiomyopathies; hypothesis-generating and should not yet change practice.
Observational
Does targeted next-generation sequencing allow for fast and comprehensive genetic characterization of patients with inherited cardiomyopathies?
Targeted next-generation sequencing provides a fast, comprehensive, and cost-efficient method for genetic screening in patients with hereditary DCM or HCM.
Meder et al. (2011) conducted an observational in Hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM). Targeted next-generation sequencing vs. Whole genome coverage was evaluated on Genomic region enrichment and mutation detection. Targeted next-generation sequencing enriched the genomic region of interest by a mean factor of 2169 compared with whole genome coverage, detecting disease-causing mutations in 6 patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: